Welcome

Welcome to Market Newsdesk! For access to published news releases, please browse below, head to our News Articles page, or use the Search function. To watch the news wires in real time, start our Real Time News app from the menu above (Chrome, Safari, or Edge browsers recommended), and click Connect. Then click on any headline to read the full article. You can also filter the incoming news by entering a Ticker symbol in the filter. Enjoy!

Articles

JanOne Completes Stable Formulation of JAN101 in Preparation for Its First GMP Manufacturing Batch to Support Upcoming Clinical Trials

JAN101 formulation ready for Phase 2b peripheral artery disease trials and for potential treatment of COVID-19 vascular inflammation PR Newswire LAS VEGAS, Aug. 11, 2020 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, together with its manufacturing partner, has successfully completed the formulation of JAN101, its potential treatment for Peripheral Artery Disease (PAD) expected to soon be in Phase 2b trials. In addition, JAN101 is planned for use to treat COVID-19 vascular complications pending approval of the IND submission, expected to be completed in late August 2020. JAN101 is one of the few promising treatments for vascular conditions using sodium nitrite that showed …

HMS to Present at the Canaccord Genuity Growth Conference on August 12th

IRVING, Texas, Aug. 11, 2020 (GLOBE NEWSWIRE) — HMS Holdings Corp.  (Nasdaq: HMSY) today announced its management team is scheduled to participate in the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020, at 8:00 a.m. ET. Management will deliver an HMS overview presentation and participate in a virtual fireside chat session.  A webcast and copy of the presentation will be available on the Company’s website at http://investor.hms.com/events-and-presentations. About HMS HMS advances the healthcare system by helping healthcare organizations reduce costs and improve health outcomes. Through our industry-leading technology, analytics and engagement solutions, we save billions of dollars annually while helping consumers lead healthier lives. HMS provides a broad range of payment accuracy and population health management solutions …

INVESTOR ALERT: Labaton Sucharow Announces Investigation of Eastman Kodak Company (NYSE:KODK) for Securities Violations and Encourages Investors to Contact the Firm

INVESTOR ALERT: Labaton Sucharow Announces Investigation of Eastman Kodak Company (NYSE:KODK) for Securities Violations and Encourages Investors to Contact the Firm NEW YORK–(BUSINESS WIRE)– Labaton Sucharow, a leading investor rights law firm is investigating possible breach of fiduciary duty claims on behalf of Eastman Kodak Company as well as securities litigation claims (“KODAK”) (NYSE: KODK). The investigation arises, in part, from a disclosure made in a Form 4 filed with the Securities and Exchange Committee (the “SEC”) (available at www.sec.gov) that KODAK’s Chief Executive Officer had been granted stock options on Monday, July 27, 2020, immediately prior to the Company publicly disclosing that it had received a $765 million loan from the U.S. Department of Defense to produce drugs to …